Catalyst Wire Dossier Catalyst Wire Dossier

ultrarapid insulin

ultrarapid insulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ultrarapid insulin, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes [NA]

See pricing